Italia Grenga

机构：AstraZeneca (United States)

发表论文 98 篇 · 总被引 2086 次 · h-index 22

代表论文

Abstract 2961: AZD9592, an EGFR/cMET bispecific antibody-drug conjugate (ADC), demonstrates target-dependent efficacy in colorectal cancer (CRC) patient-derived xenograft (PDX) models (2025 · Cancer Research · 被引 3)
Abstract 2957: Establishing preclinical activity of topoisomerase I inhibitor (TOPO1i) antibody-drug conjugate AZD9592 in patient-derived xenograft (PDX) models of metastatic colorectal cancer (mCRC) in context of irinotecan pretreatment and resistance (2025 · Cancer Research)
Abstract 2023: Multiplex immunofluorescence profiling of the tumor microenvironment and CD73: Activity of neoadjuvant oleclumab in patients with non-small-cell lung cancer in NeoCOAST (2024 · Cancer Research)
P2.04-03 EGRET: First-in-human Study of the Novel Antibody-drug Conjugate AZD9592 ± Anti-cancer Agents in Advanced Solid Tumours (2023 · Journal of Thoracic Oncology)
Supplementary Figure 2 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines (2023)
Data from Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy (2023)